End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.91 CNY | +0.65% | +0.58% | -24.11% |
May. 07 | US FDA Grants Clinical Trial Approval for Dongcheng Biochemicals' Injection | MT |
Apr. 29 | Dongcheng Biochemicals' Unit Gets Nod to Trial Tumor Drug | MT |
Sales 2024 * | 3.38B 469M | Sales 2025 * | 4B 554M | Capitalization | 11.47B 1.59B |
---|---|---|---|---|---|
Net income 2024 * | 300M 41.56M | Net income 2025 * | 484M 67.04M | EV / Sales 2024 * | 3.39 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.87 x |
P/E ratio 2024 * |
38.3
x | P/E ratio 2025 * |
23.7
x | Employees | 2,333 |
Yield 2024 * |
1.08% | Yield 2025 * |
-
| Free-Float | 63.12% |
1 day | +0.65% | ||
1 week | +0.58% | ||
Current month | +0.58% | ||
1 month | +5.78% | ||
3 months | -6.77% | ||
6 months | -28.48% | ||
Current year | -24.11% |
Managers | Title | Age | Since |
---|---|---|---|
Zhi Gang Luo
CEO | Chief Executive Officer | 53 | 18-08-09 |
Qing Lin Liu
CHM | Chairman | 53 | 98-12-30 |
Chun Ping Zhu
DFI | Director of Finance/CFO | 59 | 98-12-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shou Yi You
CHM | Chairman | 63 | 07-12-18 |
Xiao Jie Liu
BRD | Director/Board Member | 42 | 18-01-22 |
Chun Xiang Lue
PRN | Corporate Officer/Principal | 49 | 98-12-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +3.64% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 13.91 | +0.65% | 8 672 900 |
24-05-08 | 13.82 | -1.22% | 10,287,650 |
24-05-07 | 13.99 | -0.50% | 8,690,589 |
24-05-06 | 14.06 | +1.66% | 11,739,400 |
24-04-30 | 13.83 | 0.00% | 10,298,490 |
End-of-day quote Shenzhen S.E., May 08, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.11% | 1.58B | |
+18.67% | 43.74B | |
+21.99% | 22.26B | |
+16.41% | 14.9B | |
+9.03% | 13.39B | |
+40.48% | 12.12B | |
-9.64% | 6.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.41% | 5.47B |
- Stock Market
- Equities
- 002675 Stock